カテゴリ： IMARC, 世界, 医療/バイオ

筋萎縮性側索硬化症（ALS）治療薬のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）

■ 英語タイトル：Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23FB0125）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23FB0125
■ 発行日：2023年2月1日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：142
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[筋萎縮性側索硬化症（ALS）治療薬のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社の市場調査書では、2022年に719.2百万ドルであった世界の筋萎縮性側索硬化症（ALS）治療薬市場規模が2028年に969.3百万ドルへ増加し、2023年から2028年の間にCAGR 4.9％拡大すると推測されています。当書では、筋萎縮性側索硬化症（ALS）治療薬の世界市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、ALS種類別（散発性ALS、家族性ALS）分析、薬剤種類別（市販薬、新薬）分析、診断種類別（筋電図、MRI、血液検査・尿検査、脊椎穿刺、筋生検）分析、治療別（投薬、幹細胞療法、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などを整理しました。並びに、当書に掲載されている企業情報には、AB Science、Ascend Pharmaceuticals LLC、BrainStorm Cell Therapeutics Inc.、Corestem Inc.、Cytokinetics Inc.、Eledon Pharmaceuticals Inc.、Ionis Pharmaceuticals Inc.、ITF Pharma (Italfarmaco S.p.A)、Mitsubishi Chemical Group Corpotion、Revalesio Corporation and Treeway B.V.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の筋萎縮性側索硬化症（ALS）治療薬市場規模：ALS種類別
- 散発性ALSの市場規模
- 家族性ALSの市場規模
・世界の筋萎縮性側索硬化症（ALS）治療薬市場規模：薬剤種類別
- 市販薬における市場規模
- 新薬における市場規模
・世界の筋萎縮性側索硬化症（ALS）治療薬市場規模：診断種類別
- 筋電図における市場規模
- MRIにおける市場規模
- 血液検査・尿検査における市場規模
- 脊椎穿刺における市場規模
- 筋生検における市場規模
・世界の筋萎縮性側索硬化症（ALS）治療薬市場規模：治療別
- 投薬における市場規模
- 幹細胞療法における市場規模
- その他治療における市場規模
・世界の筋萎縮性側索硬化症（ALS）治療薬市場規模：地域別
- 北米の筋萎縮性側索硬化症（ALS）治療薬市場規模
- アジア太平洋の筋萎縮性側索硬化症（ALS）治療薬市場規模
- ヨーロッパの筋萎縮性側索硬化症（ALS）治療薬市場規模
- 中南米の筋萎縮性側索硬化症（ALS）治療薬市場規模
- 中東・アフリカの筋萎縮性側索硬化症（ALS）治療薬市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競合状況

The global amyotrophic lateral sclerosis treatment market size reached US$ 719.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.

Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.

Amyotrophic Lateral Sclerosis Treatment Market Trends:
The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global amyotrophic lateral sclerosis (ALS) treatment market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global amyotrophic lateral sclerosis treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on ALS type, drug type, diagnosis type, treatment and distribution channel.

Breakup by ALS Type:

Sporadic ALS
Familial ALS

Breakup by Drug Type:

Marketed Drugs
Emerging Drugs

Breakup by Diagnosis Type:

Electromyogram
MRI
Blood and Urine Tests
Spinal Tap
Muscle Biopsy

Breakup by Treatment:

Medication
Stem Cell Therapy
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.

Key Questions Answered in This Report:
How has the global amyotrophic lateral sclerosis treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
What are the key regional markets?
What is the breakup of the market based on the ALS type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the diagnosis type?
What is the breakup of the market based on the treatment?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global amyotrophic lateral sclerosis treatment market and who are the key players?
What is the degree of competition in the industry?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Amyotrophic Lateral Sclerosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by ALS Type
6.1 Sporadic ALS
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Familial ALS
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Marketed Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Emerging Drugs
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Diagnosis Type
8.1 Electromyogram
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 MRI
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Blood and Urine Tests
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Spinal Tap
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Muscle Biopsy
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Treatment
9.1 Medication
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stem Cell Therapy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AB Science
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Ascend Pharmaceuticals LLC
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 BrainStorm Cell Therapeutics Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Corestem Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Cytokinetics Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Eledon Pharmaceuticals Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Ionis Pharmaceuticals Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 ITF Pharma (Italfarmaco S.p.A)
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Mitsubishi Chemical Group Corpotion
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Revalesio Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Treeway B.V.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio

Figure 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by ALS Type (in %), 2022
Figure 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Diagnosis Type (in %), 2022
Figure 7: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Treatment (in %), 2022
Figure 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Region (in %), 2022
Figure 10: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Amyotrophic Lateral Sclerosis Treatment Industry: SWOT Analysis
Figure 90: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Value Chain Analysis
Figure 91: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Porter's Five Forces Analysis

Table 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by ALS Type (in Million US$), 2023-2028
Table 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Diagnosis Type (in Million US$), 2023-2028
Table 5: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
Table 6: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 7: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Competitive Structure
Table 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Players

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 臨床栄養のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23FB0125 )"筋萎縮性側索硬化症（ALS）治療薬のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）" (英文：Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。